Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TVTY Stock Summary
In the News
Tivity Health stock jumps after Stone Point buyout deal valued at $2 billion
Shares of Tivity Health Inc. TVTY, -1.10% rallied 1.6% in premarket trading Tuesday, after the fitness, nutrition and social connection company announced an agreement to be acquired by private equity firm Stone Point Capital in a deal valued at $2.0 billion. Under terms of the deal, Stone Point will pay $32.50 for each Tivity shares outstanding, which is 0.8% above Monday's closing price of $32.25, but represents a 20% premium to the 90-day volume-weighted average price (VWAP) ending April 4.
Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?
Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Is Tivity Health (TVTY) a Suitable Stock for Value Investors?
Let's see if Tivity Health, Inc. (TVTY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q4 2021 Results - Earnings Call Transcript
Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q4 2021 Results - Earnings Call Transcript
Tivity Health (TVTY) Lags Q4 Earnings Estimates
Tivity Health (TVTY) delivered earnings and revenue surprises of -21.05% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Tivity Health (TVTY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Tivity Health (TVTY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
TVTY or DOCS: Which Is the Better Value Stock Right Now?
TVTY vs. DOCS: Which Stock Is the Better Value Option?
Tivity Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
NASHVILLE, Tenn., Dec. 21, 2021 /PRNewswire/ -- Tivity Health, Inc. (Nasdaq: TVTY) will attend the 40th Annual J.P.
Tivity Health to Participate in Upcoming Investor Conference
NASHVILLE, Tenn., Nov. 4, 2021 /PRNewswire/ -- Tivity Health, Inc. (Nasdaq: TVTY) today announced that it will participate in the following virtual investor conference: The Credit Suisse Annual Healthcare Conference including a presentation with Richard Ashworth, President & Chief Executive Officer, Adam Holland, Chief Financial Officer and Tommy Lewis, Chief Operating Officer on Wednesday, November 10, 2021.
Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q3 2021 Results - Earnings Call Transcript
Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q3 2021 Results - Earnings Call Transcript
TVTY Financial details
TVTY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.15 | 14.08 | 24.32 | 8.89 | 9.78 | |
Net income per share | 1.56 | 2.27 | -6.17 | 1.16 | 2.18 | |
Operating cash flow per share | 2.67 | 2.52 | 1.77 | 3.44 | 1.77 | |
Free cash flow per share | 2.52 | 2.31 | 1.24 | 3.13 | 1.47 | |
Cash per share | 0.72 | 0.04 | 0.05 | 2.04 | 2.23 | |
Book value per share | 6.91 | 8.57 | 4.88 | 0.07 | 2.42 | |
Tangible book value per share | -2.33 | 0.12 | -24.03 | -7.32 | -4.97 | |
Share holders equity per share | 6.91 | 8.57 | 4.88 | 0.07 | 2.42 | |
Interest debt per share | 4.11 | 0.91 | 24.48 | 10.53 | 8.67 | |
Market cap | 1.44B | 1.07B | 946.23M | 964.16M | 1.3B | |
Enterprise value | 1.56B | 1.1B | 2.01B | 1.34B | 1.63B | |
P/E ratio | 23.49 | 10.92 | -3.3 | 16.95 | 12.12 | |
Price to sales ratio | 2.58 | 1.76 | 0.84 | 2.2 | 2.7 | |
POCF ratio | 13.66 | 9.83 | 11.5 | 5.69 | 14.94 | |
PFCF ratio | 14.48 | 10.72 | 16.43 | 6.26 | 17.98 | |
P/B Ratio | 5.29 | 2.9 | 4.17 | 263.72 | 10.94 | |
PTB ratio | 5.29 | 2.9 | 4.17 | 263.72 | 10.94 | |
EV to sales | 2.79 | 1.81 | 1.77 | 3.06 | 3.39 | |
Enterprise value over EBITDA | 12.33 | 7.88 | -10.08 | -11.47 | 9.21 | |
EV to operating cash flow | 14.78 | 10.09 | 24.37 | 7.9 | 18.75 | |
EV to free cash flow | 15.66 | 11.01 | 34.82 | 8.7 | 22.57 | |
Earnings yield | 0.04 | 0.09 | -0.3 | 0.06 | 0.08 | |
Free cash flow yield | 0.07 | 0.09 | 0.06 | 0.16 | 0.06 | |
Debt to equity | 0.54 | 0.08 | 4.68 | 129.86 | 3.3 | |
Debt to assets | 0.23 | 0.06 | 0.65 | 0.82 | 0.65 | |
Net debt to EBITDA | 0.93 | 0.21 | -5.32 | -3.21 | 1.87 | |
Current ratio | 0.62 | 0.96 | 1.11 | 1.88 | 2.24 | |
Interest coverage | 7.87 | 15.41 | -3.26 | -3.74 | 4.78 | |
Income quality | 1.65 | 1.1 | -0.29 | -0.76 | 0.83 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.06 | 0.1 | 0.1 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.57 | 0.75 | 0.83 | 0.63 | 0.61 | |
Capex to operating cash flow | -0.06 | -0.08 | -0.3 | -0.09 | -0.17 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.04 | -0.03 | |
Capex to depreciation | -1.76 | -1.94 | -0.49 | -0.34 | -1.31 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | |
Graham number | 15.55 | 20.93 | 26.02 | 1.39 | 10.89 | |
ROIC | 0.17 | 0.26 | -0.16 | -0.25 | 0.26 | |
Return on tangible assets | 0.22 | 0.83 | -1.02 | 0.26 | 0.46 | |
Graham Net | -7.48 | -1.4 | -28.06 | -9.09 | -6.51 | |
Working capital | -135.34M | -2.97M | 15.38M | 72.42M | 108.48M | |
Tangible asset value | -91.78M | 5.27M | -1.12B | -360.07M | -244.82M | |
Net current asset value | -140.92M | -34.97M | -1.24B | -421.07M | -283.73M | |
Invested capital | 0.54 | 0.08 | 4.68 | 129.86 | 3.3 | |
Average receivables | 53M | 61.51M | 82.73M | 67.29M | 51.4M | |
Average payables | 26.42M | 27.95M | 37.79M | 33.11M | 22.53M | |
Average inventory | 0 | 0 | 18.2M | 18.2M | 0 | |
Days sales outstanding | 36.14 | 40.85 | 31.49 | 30.83 | 49.92 | |
Days payables outstanding | 24.73 | 24.55 | 25.02 | 28.78 | 33.22 | |
Days of inventory on hand | 0 | 0 | 19.6 | 0 | 0 | |
Receivables turnover | 10.1 | 8.93 | 11.59 | 11.84 | 7.31 | |
Payables turnover | 14.76 | 14.87 | 14.59 | 12.68 | 10.99 | |
Inventory turnover | 0 | 0 | 18.62 | 0 | 0 | |
ROE | 0.23 | 0.27 | -1.26 | 15.55 | 0.9 | |
Capex per share | -0.15 | -0.21 | -0.53 | -0.32 | -0.3 |
Quarterly Fundamentals Overview
Last date of statement is 2022-03-31 for Q1
Metric | History | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.2 | 2.43 | 2.54 | 2.55 | 2.52 | |
Net income per share | 0.41 | 0.18 | 2.09 | -0.5 | 0.01 | |
Operating cash flow per share | 0.46 | 0.28 | 0.58 | 0.44 | 0.73 | |
Free cash flow per share | 0.43 | 0.23 | 0.53 | 0.28 | 0.68 | |
Cash per share | 1.07 | 0.49 | 2.87 | 2.21 | 2.36 | |
Book value per share | 0.53 | 0.7 | 2.83 | 2.39 | 2.53 | |
Tangible book value per share | -6.86 | -6.65 | -4.49 | -4.92 | -4.66 | |
Share holders equity per share | 0.53 | 0.7 | 2.83 | 2.39 | 2.53 | |
Interest debt per share | 8.81 | 8.3 | 8.16 | 8.02 | 7.84 | |
Market cap | 1.1B | 1.3B | 1.15B | 1.32B | 1.63B | |
Enterprise value | 1.47B | 1.68B | 1.49B | 1.65B | 1.92B | |
P/E ratio | 13.77 | 37.1 | 2.76 | -13.15 | 631.37 | |
Price to sales ratio | 10.16 | 10.84 | 9.08 | 10.38 | 12.75 | |
POCF ratio | 48.57 | 94.23 | 39.83 | 60.12 | 43.94 | |
PFCF ratio | 52.17 | 114.84 | 43.81 | 95.37 | 47.42 | |
P/B Ratio | 41.85 | 37.42 | 8.15 | 11.07 | 12.71 | |
PTB ratio | 41.85 | 37.42 | 8.15 | 11.07 | 12.71 | |
EV to sales | 13.59 | 13.98 | 11.83 | 13 | 15.09 | |
Enterprise value over EBITDA | 36.55 | 81.15 | 12.26 | -307.6 | 101.97 | |
EV to operating cash flow | 64.95 | 121.52 | 51.88 | 75.27 | 51.97 | |
EV to free cash flow | 69.76 | 148.09 | 57.06 | 119.41 | 56.09 | |
Earnings yield | 0.02 | 0.01 | 0.09 | -0.02 | 0 | |
Free cash flow yield | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | |
Debt to equity | 16.1 | 11.53 | 2.83 | 3.3 | 3.04 | |
Debt to assets | 0.78 | 0.77 | 0.63 | 0.65 | 0.65 | |
Net debt to EBITDA | 9.21 | 18.22 | 2.85 | -61.93 | 15.76 | |
Current ratio | 1.37 | 1.27 | 2.47 | 2.24 | 2.47 | |
Interest coverage | 3.49 | 1.91 | 16.19 | -1.17 | 2.24 | |
Income quality | 1.18 | 1.65 | 0.28 | -0.86 | 63.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.09 | 0.08 | 0.08 | 0.09 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.67 | 0.69 | 0.58 | 0.61 | 0.61 | |
Capex to operating cash flow | -0.07 | -0.18 | -0.09 | -0.37 | -0.07 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.06 | -0.02 | |
Capex to depreciation | -0.58 | -0.9 | -0.95 | -2.6 | -0.85 | |
Stock based compensation to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 2.21 | 1.67 | 11.52 | 5.2 | 0.85 | |
ROIC | 0.06 | 0.04 | 0.2 | -0.03 | 0 | |
Return on tangible assets | 0.11 | 0.05 | 0.39 | -0.11 | 0 | |
Graham Net | -8.67 | -8.48 | -6.03 | -6.43 | -6.02 | |
Working capital | 32.78M | 23.43M | 136.46M | 108.48M | 113.92M | |
Tangible asset value | -337.48M | -328.94M | -223.06M | -244.82M | -235.78M | |
Net current asset value | -391.74M | -380.06M | -261.48M | -283.73M | -276.04M | |
Invested capital | 16.1 | 11.53 | 2.83 | 3.3 | 3.04 | |
Average receivables | 41.36M | 53.17M | 62.28M | 64.89M | 61.92M | |
Average payables | 19.07M | 18.69M | 20.09M | 23.26M | 25.35M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 38.09 | 45.42 | 45.58 | 46.72 | 40.94 | |
Days payables outstanding | 28.91 | 24.89 | 25.59 | 29.29 | 29.13 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.36 | 1.98 | 1.97 | 1.93 | 2.2 | |
Payables turnover | 3.11 | 3.62 | 3.52 | 3.07 | 3.09 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.76 | 0.25 | 0.74 | -0.21 | 0.01 | |
Capex per share | -0.03 | -0.05 | -0.05 | -0.16 | -0.05 |
TVTY Frequently Asked Questions
What is Tivity Health, Inc. stock symbol ?
Tivity Health, Inc. is a US stock , located in Franklin of Tennessee and trading under the symbol TVTY
What is Tivity Health, Inc. stock quote today ?
Tivity Health, Inc. stock price is $- today.
Is Tivity Health, Inc. stock public?
Yes, Tivity Health, Inc. is a publicly traded company.